Authors
Abderrazzak Bentaher
Published in
Current research in microbial sciences. Volume 11. Pages 100679. Epub Oct 30, 2026.
Abstract
The respiratory microbiota constitutes a dynamic, low-biomass microbial ecosystem whose composition and function are shaped by continuous immigration, elimination, local growth conditions and host-environment interactions. Chronic obstructive pulmonary disease (COPD) provides a clinically important model in which this ecological equilibrium is profoundly altered. This review examines the lung microbiota through a "double-edged sword" framework, proposing that its biological effects depend less on the presence of individual beneficial or pathogenic taxa than on community structure, ecological stability, microbial function and host context. We examine the organization of the lung microbial ecosystem in health and its transition toward dysbiotic, unstable and pathobiont-enriched states in COPD, together with the host, environmental and therapeutic factors that shape these transitions. Particular attention is given to microbial community dynamics, functional alterations, epithelial and immune interactions, antimicrobial defense, and the contribution of the gut-lung microbial axis. We further address the unresolved directionality of the dysbiosis-COPD relationship, considering evidence that COPD-associated changes in the airway environment can select for altered microbial communities while established dysbiosis may subsequently reinforce disease-associated conditions, generating a self-perpetuating ecological cycle. Longitudinal profiling, metagenomics, metatranscriptomics, metabolomics and integrated host-microbiome approaches are discussed as means of moving beyond taxonomic associations toward microbial function and mechanism. Finally, we critically evaluate emerging microbial signatures with potential prognostic or treatment-response relevance and microbiota-targeted interventions, while emphasizing current limitations in causality, methodological standardization, strain-level resolution and clinical validation. A microbiota-centered perspective may therefore help clarify how changes in the structure and function of the lung microbiota contribute to the transition from pulmonary homeostasis to COPD-associated dysbiosis and disease progression.
PMID:
43036457
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0